Synthetic biologists aim to design biological systems for a variety of industrial and medical applications, ranging from biofuel to drug production. Synthetic gene circuits regulating efflux pump protein expression can achieve this by driving desired substrates such as biofuels, pharmaceuticals, or other chemicals out of the cell in a precisely controlled manner. However, efflux pumps may introduce implicit negative feedback by pumping out intracellular inducer molecules that control gene circuits, which then can alter gene circuit function. Therefore, synthetic gene circuits must be carefully designed and constructed for precise efflux control. Here, we provide protocols for quantitatively modeling and building synthetic gene constructs for efflux pump regulation.
Introduction
Synthetic biology aims to rationally design biological devices for specific predefined purposes [1] [2] [3] [4] [5] . This includes building synthetic gene circuits that function as switches [6] , oscillators [7] , and logic gates [8, 9] to control the secretion of substrates such as drugs or biofuels for clinical or industrial applications [10] . This goal can be achieved by expressing efflux pump proteins across the cellular membrane [11] . However, the secreted substrates can be toxic to the cells, making it important to precisely control their production, secretion, and removal. This can be achieved with synthetic gene circuits that precisely control efflux pump expression. However, efflux pumps can also lower intracellular inducer concentrations by pumping inducer molecules out of the cell along with the intended substrates. This introduces an implicit negative feedback loop that may alter the function of gene circuits that control efflux pump expression.
Previously, we built and characterized synthetic gene circuits with negative regulation and negative feedback, aptly named the "negative regulation" (NR) and "negative feedback" (NF) gene circuits [12] . Both gene circuits are TetR-based and inducible by tetracycline analogs. The NR gene circuit consists of a tetracycline repressor (TetR) driven by a P GAL1 promoter, where TetR inhibits transcription of a downstream P GAL1-D12 promoter controlling reporter gene expression in an inducer-dependent manner (Fig. 1a) . The NF gene circuit is similar to the NR gene circuit, except that TetR inhibits the transcription of its own gene as well as a reporter gene since both the genes are driven by identical P GAL1-D12 promoters (Fig. 1b) [13, 14] . Importantly, the NF gene circuit reduces gene expression heterogeneity [15] [16] [17] over a wide range of inducer concentrations, and it linearizes the dose response prior to saturation compared to other gene circuits that lack autoregulation (such as the NR circuit) [12, 18] .
Considering the importance of precise efflux control, in a recent study [11] we thoroughly investigated the efficiency and precision of controlling ATP-binding cassette (ABC) efflux pumps with low and high precision, by modifying the NR and NF gene circuits, respectively. ABC multidrug resistance pumps are highly conserved across bacteria, fungi, and mammals, and cause resistance to certain antibiotic treatments and chemotherapies by pumping a wide range of compounds out of the cell [19] [20] [21] . To build the NRpump (Fig. 1c) and NFpump ( Fig. 1d) Using inducible synthetic gene circuits to control efflux pump expression could mitigate the toxicity of secreted biochemicals while ensuring proper yield. However, while designing such systems, consideration should be given to the implicit feedback that results from the efflux pumps acting not only on their intended substrate, but also on the inducer. In this chapter, we describe step by step the protocols required to mathematically model and build synthetic gene circuits for efflux pump control. This should be useful for basic research (e.g., studies of efflux-pump-mediated drug resistance), as well as industrial and biomedical applications, and also for predicting and understanding the consequences of modifying natural or synthetic gene networks that regulate an efflux pump or other active target genes. Insert-f: 5′-AATTGGAGCGACCTCATGCTATACCTG-3′
1. G418, 100 μg/mL, 200 μg/mL, 300 μg/mL, 400 μg/mL 500 μg/mL.
2. PEG, 50% w/v (molecular weight 3350).
3. Lithium Acetate, 1.0 M and 100 mM. 2. Synthetic complete medium (per liter): 6.7 g of nitrogen base without amino acids, 2 g of drop-out mix with complete amino acids, 19 mg adenine, add deionized water to 900 mL, autoclave, then add 100 mL 20% glucose or galactose.
3. Synthetic dropout medium without certain amino acid(s) (per liter): 6.7 g of nitrogen base without amino acids, 2 g drop-out mix without certain amino acid, 19 mg adenine, add deionized water to 900 mL, autoclave, then add 100 mL 20% glucose or galactose.
1. Same reagents as in yeast cell transformation (Subheading 2.3).
2. Primers used for PDR5 knockout:
Kan B: 5′-CTGCAGCGAGGAGCCGTAAT-3′
Kan C: 5′-TGATTTTGATGACGAGCGTAAT-3′
Yeast Cell Transformation

Medium
Endogenous PDR5 Knockout
1. QuickChange II XL site-directed mutagenesis kit.
2. Plasmid constructed with the PDR5::GFP gene.
3. 14 mL BD Falcon polypropylene round-bottom tubes.
4. 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal, 80 μg/mL).
5. Isopropyl-1-thio-beta-D-galactopyranoside (IPTG, 20 μM).
6. pH 7.5 NYZ+ Broth (per liter): 10 g of NZ amine, 5 g of yeast extract, 5 g of NaCl, add deionized H 2 O to 1 L, NaOH (for pH adjustment).
7. LB Agar (per liter): 1 g of NaCl, 10 g of trypotone, 3 g of yeast extract, 20 g of agar.
8. Primers used for site-directed mutagenesis:
5′-CGCTTCCTTTCAGCACCG GAAACACCTCTGACGATGTCGTTACC-3′ 9. Sequencing primers used to confirm PDR5 mutations:
Insert-f from Subheading 2.2 and GALSeqA-f (anneals to pRS4* plasmids in the DNA region immediately upstream of the pGAL10-controlled gene):
5′-CAAACCTCTGGCGAAGAATTG-3′
A software environment such as Matlab (The Mathworks, Inc., https://www.mathworks.com) with the SimBiology, Symbolic Math, and Statistics toolboxes can be used for stochastic simulations, calculations, and statistics. Alternatively, non-commercial, freely available software such as Octave [23] , Dizzy [24], or Python (Python Software Foundation, https://www.python.org) can be used for the same purpose.
Methods
Here, we describe the construction of the reporter plasmid with the PDR5::GFP gene [22] under the control of the TetRrepressible P GAL1-D12 promoter [14] . It also has the HIS3 gene as the auxotrophic marker for S. cerevisiae and the extended pet56-his3Δ200 locus [25] for chromosomal integration. Construction consists of two steps: insertion of the PDR5::GFP gene into the plasmid (Protocol A) and addition of the pet56-his3Δ200 locus 2. Digest the PCR product from step 1 with the AflII and XhoI restriction enzymes. This will result in two fragments, small and large (~400 bp and ~4900 bp, respectively). Run the reaction products in agarose gel electrophoresis and extract both the fragments using a gel extraction kit of your choice.
3. Perform a second digestion reaction of the small fragment from step 2 using the BamHI enzyme and clear it up using a kit of your choice.
4. Digest the pDN-G1GZmbh [12, 26] plasmid with the BamHI and XhoI restriction enzymes. Separate the reaction products using agarose gel electrophoresis and extract the large fragment (backbone) using a gel extraction kit of your choice.
5. Perform a sticky-end ligation reaction using the backbone fragment from step 4 and both the small and large digested PCR fragments from steps 2-3 to produce a plasmid with the PDR5::GFP gene inserted into the backbone. Run the ligation reaction overnight at room temperature to increase efficiency.
6. The following day, transform competent E. coli cells with the product from the overnight ligation and seed bacteria onto a selective agar plate with added ampicillin to select for transformed cells. Incubate the plate in a 37 °C incubator overnight.
7. Pick several colonies from the plate from step 6 and grow them separately overnight in the LB medium with ampicillin added. Purify the plasmids using a miniprep kit of your choice.
8. Sequence the plasmid samples with the primers for PDR5::GFP verification (Materials and Methods, Subheading 2.2, item 4) to confirm proper insertion of the gene into the plasmid. If all the steps are successful, this protocol will result in the intermediate plasmid pDN-G1PGbh.
1. Digest both pDN-G1PGbh from Protocol A and pDNT2dPGxh [25] plasmids with the AhdI and AvrII restriction enzymes. Separate reaction products using agarose gel electro-
Protocol A
Protocol B
Negative Regulation Gene Circuits phoresis and extract the large fragment of pDN-G1PGbh and the small fragment of pDN-T2dPGxh using a gel extraction kit of your choice.
2. Perform a sticky-end ligation reaction using both the extracted fragments from step 1 to produce a plasmid with the pet56-his3Δ200 locus inserted into the backbone. For better efficiency, run the ligation reaction overnight at room temperature.
3. Follow the E. coli transformation and DNA preparation procedures as described in steps 6-7 of Protocol A.
4. Sequence the plasmid samples with the primers for pet56-his3Δ200 locus verification (Materials and Methods, Subheading 2.2, item 5) to confirm proper insertion of the sequence into the plasmid. If all the steps are successful, this protocol will result in the pDN-G1PGlbh plasmid, which will be further used for yeast transformation (see Note 5 with regards to homology locus for yeast transformation).
1. Pick up a single colony from a yeast cell plate and inoculate into 5 mL synthetic complete (SC) medium. Depending on the yeast strain, the SC medium can be substituted by synthetic drop-out (SD) medium (e.g., SD medium without histidine or trypsin). Shake the cell culture in an incubator at 300 rpm and 30 °C overnight.
2. Measure cell density of the overnight culture on a Nexcelom cell counter, calculate the cell culture volume that contains 2.5 × 10 8 cells, inoculate the calculated volume of cell culture into 50 mL fresh SC (or SD) medium to reach a cell density of 5 × 10 6 /mL.
3. Shake the cell culture in an incubator at 300 rpm and 30 °C for 3-5 h, until the cell density reaches 2 × 10 7 /mL.
4. Harvest the cells in sterile 50 mL centrifuge tubes at 8000 × g for 4 min.
5. Pour off the supernatant carefully, resuspend the cell pellets with 25 mL sterile H 2 O, and centrifuge again.
6. Repeat step 5 one time.
7. Pour off the supernatant carefully, and resuspend the cells with 1 mL Lithium Acetate (100 mM) thoroughly, and transfer the suspension to a sterile 1.5 mL tube.
8. Centrifuge the suspension at 13,000 × g for 5 s, then remove the supernatant with a pipette.
9. Resuspend the cell pellet with 500 μL Lithium Acetate (100 mM), mix thoroughly by pipetting and vertexing.
Yeast Cell Transformation
10. Boil 100 μL (50 μL for control, 50 μL for experimental sample) salmon sperm DNA for 5 min, and quickly chill on ice or in ice water. Keep on ice before using for transformation (see Note 6).
11. Vortex the cell suspension and pipette 50 μL samples into a pre-labeled 1.5 mL tube (sterile); pellet the cells and remove the Lithium Acetate supernatant with a pipette.
12. Make transformation mix containing the following ingredients, carefully add them into the cell pellets in the order listed below:
240 μL of PEG 3350.
36 μL of Lithium Acetate (1 M).
50 μL of salmon sperm DNA.
34 μL of linearized plasmid DNA (0.1-10 μg) or sterile H 2 O for control (see Note 7).
13. Vortex each tube vigorously until the cell pellet has been completely mixed. This usually takes at least 1 min.
14. Incubate the mixture at 30 °C for 30 min. Shake the tubes, turning them upside down repeatedly or use a thermomixer at 600 rpm.
15. Heat shock for 20 min at 42 °C, and then chill on ice for 2 min.
16. Centrifuge the cells at 8000 × g for 30 s, and then remove the supernatant with a pipette.
17. Pipette 1 mL sterile H 2 O into the 1.5 mL tube, and resuspend the cell pellets gently.
18. Take 100 μL cell culture, dilute it 10 times and 100 times separately.
19. Plate 100 μL aliquots of the original transformation mix, 10 times dilution and 100 times dilution onto 3 selective plates separately.
The construction of PDR5 containing gene circuits follows a similar method as other gene circuits described before [12] . Each synthetic gene circuit is created by integrating two separate plasmids-reporter and regulator. The reporter plasmid, as described in Subheading 3.1, contained PDR5::GFP gene [22] under the control of TetR-repressible PGAL1-D12 promoter [13] . The regulatory plasmid contained the gene encoding the TetR repressor as the regulator [11, 12] . We developed all regulatory circuits earlier [12] and described them in detail in a previous book chapter [26] . We created a total of 12 PDR5-containing synthetic gene circuits, which are single-color and double-color versions of the following (including 4 PDR5 mutants for control purposes): NRpump, NFpump, NRpump558, NFpump558, NRpump312, and NFpump312.
Construction of PDR5-Containing Synthetic Gene Circuits
All the PDR5-containing gene circuits were transformed into haploid S. cerevisiae strain YPH500 (α, ura3-52, lys2-801, ade2-101, trp1Δ63, his3Δ200, and leu2Δ1) (Stratagene) to create strains containing these synthetic gene circuits, which had a chromosomally integrated pet56-his3Δ200 locus in their genome as described previously [25] . In the NRpump558/312 and NFpump558/312 versions, a single nucleotide mutation was introduced into the PDR5 gene before following the same procedure for yeast genomic integration. In the S558Y mutant, the C base of the PDR5 gene was changed to A at position 1673, while the G base was changed to C at position 935 in the G312A mutant. These mutants lack pump function and can serve as controls. Additionally, since PDR5-controling gene circuit integration can alter regulator expression, we also constructed 2-color versions of each gene circuit. In these 2-color gene circuits, the regulator gene tetR was replaced with the tetR::mCherry fusion gene in the regulator plasmid. Other procedures were the same for genomic integration. Finally, colonies with single integration were selected by PCR and flow cytometry as described before [12] . All cell cultures were grown in the YPD medium, synthetic complete medium, or synthetic drop-out medium with appropriate selection markers and 2% galactose or glucose.
To make a kill curve to optimize the concentration of the selection agent, here we investigated the response to G418. The concentration must distinguish G418 resistance strains from non-resistance strains. Use any KanMX4 cassette containing strain from the same genetic background as positive control, since they are resistant to G418 (see Note 8).
1. Prepare YPD plates containing 400 μg/mL G418. For knocking out PDR5, we replace the endogenous PDR5 gene with a G418-resistant gene. 4. Transformation: follow the protocol in Subheading 3.2 for transformation. We used 0.3 μg of PCR products for transformation. Remember to include your negative control (no DNA in transformation) in the experiment.
5. Selection of knockout clones by confirmation PCR. Follow the protocol on the yeast deletion webpage (www-sequence.stanford.edu/group/yeast_deletion_project). Successful deletion can be confirmed by two PCR products with primer A and KanB, and primer D and KanC, while no product with primer A and B, or primer C and D. Otherwise, the knockout has failed and the procedure should be repeated.
There are three main steps in the mutagenesis process as listed below, each step has detailed instruction provided in the Agilent QuickChange II XL site-directed mutagenesis kit. Make sure to include the control reaction provided in the kit.
1. Run a PCR reaction with the designed primes containing the specific site mutation to amplify the entire plasmid.
2. Digest the template plasmid using DpnI restriction enzyme (NEB).
Transform competent E. coli cells provided in the kit (see Note 9).
This experiment determines the time for each strain to reach saturation, because cells need to grow in exponential phase to maintain stable growth conditions for the experiments. The goal of this measurement is to determine the starting cell density and the time for each strain to reach saturation without an inducer.
1. Pick a single colony from the yeast plate, inoculate into 1 mL SD medium with 2% glucose, incubate at 30 °C, shaking at 300 rpm overnight.
2. Measure cell density with a Nexcelom cell counter, and inoculate 5 × 10 5 cells into 1 mL SD medium with 2% galactose and appropriate selection marker. Then, incubate at 30 °C, while shaking at 300 rpm.
3. Measure cell density every 2 h for 24 h or until cell growth reaches stationary phase, meaning no cell density change in two consecutive measurements.
Site-Directed Mutagenesis
Identification of Optimal Cell Culture Time for each Strain
4. Plot the growth curves and estimate the time it takes for each strain to reach the stationary phase.
1. Streak cells from frozen stock on a selection plate with 2% glucose, incubate at 30 °C for 2 days.
2. Inoculate a single colony into SD medium with a selection marker and 2% glucose, incubate in the 30 °C incubator shaking at 300 rpm overnight.
3. Measure cell density with the Nexcelom cell counter, and inoculate 5 × 10 5 cells into 1 mL SD medium with 2% galactose, selection marker, and increasing concentrations of inducer (doxycycline). Incubate at 30 °C, and shaking at 300 rpm.
4. Measure cell density every 12 h and resuspend cells in fresh medium with starting cell density of 5 × 10 5 cells/mL. Measure cell density during the entire dose-response experiment.
1. Grow cells as described in Subheading 2.6 for 3 days until PDR5 expression becomes stable as measured by flow cytometry, meaning no significant change of GFP fluorescence distribution over two consecutive days.
2. Transfer cell culture from culture tube to sterilized 1.5 mL Eppendorf tube, centrifuge at 8000 × g for 3 min.
3. Remove the supernatant by pipetting, add 500 μL ice cold PBS into the cell pellet, resuspend the cells and mix well by vortexing, centrifuge at 8000 × g for 3 min.
4. Repeat step 3.
5. Measure cell density with Nexcelom cell counter, resuspend cells into 100 μL fresh SD medium with a cell density of 5 × 10 5 cells/mL.
6. Dissolve Calcein-AM red dry powder into DMSO, and prepare stock solution with concentration at 50 μg/mL. 
Measurement of Reporter Gene Expression
Single-laser flow cytometer (FASCScan) data analysis:
1. Extract FSC, SSC, and FL1 (green fluorescence intensity) using the FACScan data package in Matlab (see Note 10).
2. To reduce extrinsic noise, apply a gate based on FSC and SSC, and select the gated area to include the highest cell density in each sample.
3. Read and process FL1 data based on the gating.
4. Calculate the arithmetic mean and standard deviation; exclude outliers, that is, any data point outside of three times the standard deviation, from the data set.
5. Subtract the FL1 value of YPH500 strain from that of each sample (see Note 11).
6. Normalize the mean of each sample to the sample in its corresponding strain that was induced at the highest doxycycline concentration.
7. Calculate arithmetic mean and CV of processed FL1 value.
8. Plot arithmetic mean and CV against doxycycline concentrations.
Two-laser flow cytometer (FACSAria II) data analysis:
1. Extract FSC, SSC, FL1 (green fluorescence intensity) and FL3 (red fluorescence intensity) using .fcs file reader scripts (such as fcsread) in Matlab (see Note 10).
2. The following steps are identical to the single-laser data analysis above, except that the mean and CV are calculated for both FL1 and FL3, and then plotted against doxycycline concentrations separately for each 2-color strain.
1. Develop a set of statements (facts from the known biology and reasonable assumptions) about the system. For example, for the NRpump gene circuit (Fig. 1c) (c) TetR binds irreversibly to doxycycline and is inactivated when bound.
(d) For doxycycline to bind to TetR, it must diffuse into the cell from the extracellular environment.
(e) The PDR5 protein is an efflux pump that transports doxycycline out of the cell.
Data Analysis
Mathematical and Computational Modeling
These statements can be translated into a set of biochemical reactions and then a mathematical model. E.g., the set of ordinary differential equations (ODEs) for NRpump is: 2. Estimate parameters to describe the model system. To obtain the exact values for these parameters for our experiment we fit the following analytic solution for z as a function of the control parameter C available for the NR gene circuit [14] to the experimental data: 8. Most online protocols recommend using 200 μg/mL G418 for selection, but 400 μg/mL worked best for us.
9. Please make sure to use polypropylene round-bottom tubes, since tubes made of other materials can cause very low transformation rate.
10. Please contact us if you have questions about the Matlab code.
11. The YPH500 strain itself generates a low autofluorescence signal, which may need to be subtracted from the data.
12. The Matlab script is also available at: https://github.com/ dacharle42/NRpump_SSA_MiMB.git.
13. Simulate the reaction equations using the Gillespie stochastic simulation algorithm [28] in Matlab (see Box 1) [27] or other software such as Dizzy [24] . Execute code over many independent runs to generate gene expression statistics for plotting and analysis. In practice, the number of runs is increased until the statistics do not change except within a small margin of error. To normalize the results, divide the mean reporter-pump protein number for each inducer concentration by the value obtained for the highest inducer concentration.
14. The reaction rate of inducer influx into the cell is given by dox*c, where dox is the concentration of extracellular doxycycline and c is the membrane permeability.
